Drug Profile
Respiratory syncytial virus vaccine - Pharmacia
Alternative Names: U 87808Latest Information Update: 24 Oct 2021
Price :
$50
*
At a glance
- Originator Pharmacia Corporation
- Class Respiratory syncytial virus vaccines; Synthetic vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Respiratory syncytial virus infections
Most Recent Events
- 25 Jun 2001 No-Development-Reported for Respiratory syncytial virus infections in USA (Unknown route)
- 05 Apr 2000 Pharmacia & Upjohn has merged with Monsanto to form Pharmacia Corporation
- 06 May 1996 Preclinical development for Respiratory syncytial virus infections in USA (Unknown route)